Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases

Area of Science:

• Genetics and immunology
• Neuroimmunology
• Gastroenterology

Background:

• Epidemiological studies confirm an association between multiple sclerosis (MS) and inflammatory bowel disease (IBD).
• The underlying shared genetic etiology between MS and IBD subtypes, ulcerative colitis (UC) and Crohn's disease (CD), remains largely undetermined.
• Understanding the genetic relationship is crucial for elucidating the biological basis of this comorbidity.

Purpose of the Study:

• To investigate the shared genetic architecture between MS and IBD overall, and between MS and UC/CD independently.
• To identify specific genetic variants (SNPs) contributing to the comorbidity.
• To explore potential causal relationships and tissue/cell-type-specific genetic enrichments.

Main Methods:

• Utilized large-scale genome-wide association study (GWAS) summary data.
• Performed cross-trait meta-analyses to identify shared SNPs.
• Applied Mendelian randomization to assess causal effects.
• Analyzed tissue-specific and cell-type-specific heritability enrichment.

Main Results:

• Identified a significantly greater genetic correlation between MS and UC compared to MS and CD.
• Discovered three SNPs shared across MS, IBD, UC, and CD.
• Found suggestive evidence for a causal effect of MS on UC and IBD, but not vice versa.
• Observed consistent tissue-specific heritability enrichment in lung, spleen, blood, and small intestine.
• Detected cell-type-specific enrichment in CD4+ T cells (lung) and CD8+ cytotoxic T cells (lung and spleen).

Conclusions:

• MS and UC share a stronger genetic basis than MS and CD.
• MS may have a causal influence on the development of UC and IBD.
• Shared genetic factors and immune cell pathways in specific tissues contribute to the comorbidity of MS and IBD.